1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drug-Induced Cardiovascular Disease

Drug-Induced Cardiovascular Disease

226 - 240 of 247 Results
Sort Results:
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (2008) June 2008
Guideline: AAP Policy Statement on Cardiovascular Monitoring and Stimulant Drugs for ADHD (Addendum May 2008: On May 28, 2008, the American Academy of Pediatrics (AAP) released a statement on cardiovascular monitoring in children and adolescents taking ADHD medications. The AAP does not recommend screening ECGs unless the patient's history, family history, or the physical examination raises concerns.) June 2008
Guideline: Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Stimulant Drugs (Correction) (2009) June 2008
Commentary: Cardiovascular Screening and Monitoring Of Children and Adolescents Receiving ADHD Drugs June 2008
Patient Education: Patient Handout to Go Along with Your MedGuide for ADHD Drugs June 2008
Guideline: ACC/AHA 2007 Focused Update of the 2004 Guidelines For the Management of Patients with ST-Elevation Myocardial Infarction February 2008
Commentary: NSAID Use in Patients with Unstable Angina or Myocardial Infarction February 2008
Guideline: ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction February 2008
Guideline: AHA Scientific Statement on Use of Nonsteroidal Anti-Inflammatory Drugs (2007) February 2008
Chart: Drug-induced Long QT Interval November 2007
Article: Prilosec and Nexium might cause heart problems September 2007
Guideline: National Kidney Foundation Guideline and Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target June 2007
Commentary: Safe Use of Erythropoiesis-Stimulating Agents (ESAs) June 2007
Article: Qualaquin, the only quinine that FDA allows on the market, is too expensive May 2007
Patient Education: Quinine and Preventing Leg Cramps May 2007